In order to simplify India’s pharma foreign trade procedures, the Directorate General of Foreign Trade (DGFT) has announced key amendments to Para 2.08 of the Handbook of Procedures (HBP) 2023. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback